7-year follow-up atherosclerotic plaque progression in patients with antiphospholipid syndrome versus diabetes mellitus and healthy controls.

Gerasimos EvangelatosNikolaos TentolourisPetros P SfikakisMaria G G Tektonidou

Published in: Rheumatology (Oxford, England) (2024)

Half of APS patients develop new atherosclerotic plaques over a 7-year follow-up, having a three-times higher risk vs HC. Concomitant SLE and number of traditional CVRFs are associated with plaque progression, supporting the need for thorough CVRF assessment and control.

Keyphrases

end stage renal disease
ejection fraction
coronary artery disease
newly diagnosed
systemic lupus erythematosus
chronic kidney disease
prognostic factors
metabolic syndrome
patient reported outcomes
disease activity
skeletal muscle